Clinical Trial Update: A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 study update reporting safety, tolerability, and pharmacokinetics of oral doses of TCK-276 in patients with rheumatoid arthritis; results were posted on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TCK-276

Snippet

Sponsor: Teijin America, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2024-10-15